Department of Cardiovascular Science, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK.
Haemophilia. 2012 Jul;18 Suppl 4:48-53. doi: 10.1111/j.1365-2516.2012.02829.x.
The management of patients with inhibitors is the greatest challenge facing haemophilia health professionals. Immune tolerance induction (ITI) can be successful in eliminating the inhibitor in the majority of patients, provided it is started soon after the inhibitor develops and the titre of the inhibitor is <10 BU at commencement of ITI. Acute bleeding is treated using one of two bypassing agents, which exhibit similar efficacy and safety. Surgery in inhibitor patients is challenging and should only be carried out in experienced centres.
抑制物患者的管理是血友病专业医护人员面临的最大挑战。免疫耐受诱导(ITI)在大多数患者中可以成功消除抑制剂,只要它在抑制剂产生后不久开始,并且抑制剂的效价在 ITI 开始时<10BU。急性出血的治疗使用两种旁路制剂之一,这两种制剂具有相似的疗效和安全性。抑制剂患者的手术具有挑战性,应仅在有经验的中心进行。